Startups
Edit

Cerbios-Pharma SA

Trusted
http://www.cerbios.ch/
Last activity: 09.10.2026
Active
Categories: ActiveBusinessChemicalCommerceDevelopmentManufacturingProductionResearchSupplyVitamin
Cerbios is a swiss privately held company specialized in the development and manufacturing of chemical and biological APIs for its world-wide partners.

The exclusive R&D and manufacturing expertise is available to our Pharma partners needing to develop and scale-up NCE or NBE for clinical trials, registration and commercial purpose.

cGMP APIs made by Cerbios in its FDA inspected site in Switzerland are sold worldwide mainly to pharma companies including EU, USA and Japan.

Cerbios is specialized in Reduced Folates (world leader position) but also in the manufacturing of High Potency Active Ingredients (HPAPIs) with a series of Vitamin D derivatives requiring sophisticated production units with high containment levels.

Another core business is the research, development and production of Probiotics of Pharma quality.
On top of that, in the last 17 years, CERBIOS has acquired a vast experience with Recombinant Proteins from mammalian cells (CHO) based on a state-of-the-art platform.

Service for third parties in exclusive manufacturing is concentrated in the area of HPAPI and Recombinant Proteins.

Full CMC support is given to our customers in order to provide them with the supply of cGMP clinical batches, registration/validation material and commercial manufacturing. Paramount to that is the supply of all documentation required for a successful registration.
Followers
7.37K
Mentions
1

Overview

Location
Switzerland, Ticino, Lugano
Employees
51-200
Founded date
1976

Mentions in press and media 1

DateTitleDescription
Sign up to seeSign up to seeSign up to see

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Cerbios-Pharma SA

When was Cerbios-Pharma SA founded?

Cerbios-Pharma SA was founded in 1976.

Is Cerbios-Pharma SA still active?

Yes, Cerbios-Pharma SA is active; its latest activity on Parsers VC dates from Oct 9, 2026.